We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.27%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$8.87B
AUM Growth
+$1.06B
(+14%)
Cap. Flow
+$639M
Cap. Flow
% of AUM
7.2%
Top 10 Holdings %
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,198
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$37.2M |
| 2 |
Linde
LIN
|
+$31.4M |
| 3 |
Take-Two Interactive
TTWO
|
+$30M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$27.4M |
| 5 |
Walmart Inc
WMT
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$46.1M |
| 2 |
PayPal
PYPL
|
+$31.4M |
| 3 |
Apple
AAPL
|
+$31.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$28M |
| 5 |
Merck
MRK
|
+$27.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Consumer Discretionary | 15.85% |
| 3 | Healthcare | 13.89% |
| 4 | Industrials | 12.4% |
| 5 | Financials | 11.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRNS
2576
Barinthus Biotherapeutics
BRNS
$24.5M
| $194K | ﹤0.01% |
+11,562
| New | +$171K |
|
2577
Arbutus Biopharma
ABUS
$915M
| $193K | ﹤0.01% |
63,700
-121,815
| -66% | -$377K |
|
|
CAMP
2578
DELISTED
CalAmp Corp.
CAMP
| $193K | ﹤0.01% |
660
+108
| +20% | +$32.2K |
|
2579
Xeris Biopharma Holdings
XERS
$1.45B
| $192K | ﹤0.01% |
47,230
-13,785
| -23% | -$52.6K |
|
|
TBRG
2580
DELISTED
TruBridge
TBRG
| $192K | ﹤0.01% |
+5,766
| New | +$183K |
|
2581
Accuray
ARAY
$34M
| $191K | ﹤0.01% |
42,286
-2,311
| -5% | -$10.8K |
|
2582
Coeur Mining
CDE
$17.9B
| $191K | ﹤0.01% |
21,535
+7,906
| +58% | +$76.2K |
|
2583
G-III Apparel Group
GIII
$1.5B
| $191K | ﹤0.01% |
5,823
-21,391
| -79% | -$692K |
|
2584
Root
ROOT
$798M
| $191K | ﹤0.01% |
+981
| New | +$185K |
|
2585
HCI Group
HCI
$2.41B
| $190K | ﹤0.01% |
1,909
+1,055
| +124% | +$85.6K |
|
|
KRON
2586
DELISTED
Kronos Bio
KRON
| $189K | ﹤0.01% |
+7,905
| New | +$200K |
|
2587
Amneal Pharmaceuticals
AMRX
$5.79B
| $187K | ﹤0.01% |
36,542
-253,754
| -87% | -$1.44M |
|
|
LBAI
2588
DELISTED
Lakeland Bancorp Inc
LBAI
| $186K | ﹤0.01% |
+10,660
| New | +$193K |
|
2589
Custom Truck One Source
CTOS
$2.37B
| $185K | ﹤0.01% |
+19,416
| New | +$191K |
|
2590
The Greenbrier Companies
GBX
$1.46B
| $185K | ﹤0.01% |
4,242
-9,087
| -68% | -$420K |
|
2591
Hercules Capital
HTGC
$3.23B
| $184K | ﹤0.01% |
10,783
-20,150
| -65% | -$345K |
|
|
LEV
2592
DELISTED
The Lion Electric Company
LEV
| $184K | ﹤0.01% |
+9,445
| New | +$177K |
|
2593
Live Oak Bancshares
LOB
$1.97B
| $183K | ﹤0.01% |
3,105
+19
| +0.6% | +$1.19K |
|
2594
Cadiz
CDZI
$291M
| $182K | ﹤0.01% |
+13,352
| New | +$160K |
|
|
NOA
2595
North American Construction
NOA
$395M
| $182K | ﹤0.01% |
+11,941
| New | +$159K |
|
|
TRVN
2596
DELISTED
Trevena, Inc.
TRVN
| $182K | ﹤0.01% |
172
-284
| -62% | -$318K |
|
|
AUD
2597
DELISTED
Audacy, Inc.
AUD
| $182K | ﹤0.01% |
42,122
-13,996
| -25% | -$64.3K |
|
2598
Concrete Pumping Holdings
BBCP
$491M
| $180K | ﹤0.01% |
21,217
+9,920
| +88% | +$79.4K |
|
2599
Kimbell Royalty Partners
KRP
$1.48B
| $180K | ﹤0.01% |
+14,022
| New | +$167K |
|
2600
Myriad Genetics
MYGN
$312M
| $180K | ﹤0.01% |
5,901
-2,785
| -32% | -$80.5K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2021 Portfolio in Review
As of Q2 2021, Cubist Systematic Strategies held 3,246 positions worth $8.87B, up 14% from $7.81B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
Cubist Systematic Strategies deployed $639M of net new capital in Q2 2021, opening 442 new positions and adding to 1,245 existing holdings. Its largest new stake was American Tower: 39,022 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Aptiv, an estimated $46.1M trimmed.
- Cubist Systematic Strategies's largest Q2 2021 buy was American Tower: 39,022 shares worth $10.5M.
- Cubist Systematic Strategies added most to Okta in Q2 2021, an estimated $37.2M increase.
- Cubist Systematic Strategies's biggest Q2 2021 reduction was Aptiv, cutting an estimated $46.1M.
- Cubist Systematic Strategies fully exited Toro Company in Q2 2021, selling an estimated $7.31M.
- Cubist Systematic Strategies's ten largest holdings make up 4.2% of its $8.87B portfolio in Q2 2021.
- Cubist Systematic Strategies opened 442 new positions and closed 351 in Q2 2021.
- Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $8.87B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.